8513 (8513) Fair Value & Analysis
Healthcare · Market cap HK$34.8M
Fair value as of: Jul 3, 2026
From 11 valuation models · updated today
Share price −4.5% over the past month.
Price vs Fair Value (12 months)
12‑month range HK$0.4050 – HK$1.49 · fair‑value band HK$0.4400 – HK$0.7400 · the HK$0.4250 price screens below the HK$0.5900 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
8513 (8513) currently trades at HK$0.4250, while our model-based Fair Value estimate is HK$0.5900 — implying the stock looks roughly 38.8% undervalued today. We read business quality at 39/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, 8513 generated revenue of HK$18.6M at a net margin of -3.3%. Revenue grew 106.2% year over year. It earns a return on equity of -33.7%. Net debt stands at HK$1.5M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
8513 reported revenue of HK$18.6M in FY2025 versus HK$19.8M in FY2021, a compound −1.5%/yr. Reported net income was −HK$612K in FY2025.
Is 8513 fairly valued? → Check now
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $412.02 | $165.35 | -60% |
| EssilorLuxottica Société anonyme ESLOF | $192.00 | $126.51 | -34% |
| HOYA Corporation HOCPY | $178.46 | $103.27 | -42% |
| Medline Inc MDLN | $34.71 | $30.15 | -13% |
| Becton, Dickinson and Company BDX | $140.71 | $104.17 | -26% |
| Alcon Inc ALC | $66.58 | $36.99 | -44% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 8513 (8513) undervalued?
What is the fair value of 8513?
What is the quality score of 8513?
What is the revenue of 8513 (8513)?
What is the net profit margin of 8513?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.